ASBP
Aspire Biopharma Holdings Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$1.05
-0.07 ▼ -6.67%
🌙 3월 13일 6:41 PM ET (한국 3/14 07:41)
$1.07
+0.02 ▲ +1.90%
| Index | - | P/E | - | EPS (ttm) | -65.94 | Insider Own | 10.84% | Shs Outstand | 0.01B | Perf Week | -9.48% |
| Market Cap | 0.01B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | 0.00B | Perf Month | -22.22% |
| Enterprise Value | 0.01B | PEG | - | EPS next Q | - | Inst Own | 8.74% | Short Float | 8.96% | Perf Quarter | -69.23% |
| Income | -0.03B | P/S | - | EPS this Y | - | Inst Trans | 5.64% | Short Ratio | 0.4 | Perf Half Y | -94.19% |
| Sales | 0.00B | P/B | - | EPS next 5Y | - | ROA | -633.21% | Short Interest | 0.40M | Perf YTD | -80.1% |
| Book/sh | -9.26 | P/C | 2.71 | EPS past 3/5Y | - | ROE | -490.07% | 52W High | -97% ($35.01) | Perf Year | -95.47% |
| Cash/sh | 0.39 | P/FCF | - | Sales past 3/5Y | - | ROIC | - | 52W Low | -5.41% ($1.11) | Perf 3Y | -99.75% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -282.04% | Gross Margin | 45.54% | Volatility(W/M) | 9.62% 11.91% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | -901693.3% | ATR (14) | 0.21 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 0.17 | EPS Q/Q | 45.98% | Profit Margin | - | RSI (14) | 32.79 | Recom | - |
| Dividend Gr. 3/5Y | - | Current Ratio | 0.17 | Sales Q/Q | - | SMA20 | -22.15% ($1.35) | Beta | 0.94 | Target Price | - |
| Payout | - | Debt/Eq | - | Earnings | - | SMA50 | -49.04% ($2.06) | Rel Volume | 0.16 | Prev Close | $1.12 |
| Employees | - | LT Debt/Eq | - | EPS/Sales Surpr. | - | SMA200 | -89.7% ($10.19) | Avg Volume(3M) | 1.01M | Price | $1.05 |
| IPO | 2022/4/11 | Option/Short | No/Yes | Trades | 571 | Volume | 163,852 | Change | -6.67% |
뉴스 로딩 중...